| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Systemic lupus erythematosus | 1,445 | 15 | |
| Multiple sclerosis | 609 | 361 | |
| Chronic obstructive pulmonary disease | 402 | 7 | |
| Prevent organ rejection | 220 | 18 | |
| Optic neuritis | 92 | 28 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Insomnia | 78 | |
| Metallic taste in mouth | 71 | |
| Weight gain | 61 | |
| Increased appetite | 46 | |
| Change in taste | 39 | |
| Headaches | 39 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 142 | |
| Moderate | 301 | |
| Mild | 270 | |
| None | 212 |
Member evaluations
dig
evaluated on Jul 23, 2010
- Perceived effectiveness for relapse MS (exacerbation): Major
- Side effects: None
Raineyhayward
evaluated on Nov 21, 2010
- Perceived effectiveness for transplant rejection prevention: Moderate
- Side effects: Moderate
Ellaj35
evaluated on Aug 19, 2010
- Perceived effectiveness for inflammation: None
- Side effects: Mild